Duke faculty members Megan E.B. Clowse, MD, MPH, and Lisa G. Criscione-Schreiber, MD, discuss “The Great Debate,” which focuses on the optimal treatment approach for RA and strategies to balance therapeutic efficacy and cost with available agents.
Highlights From the 2013 Rheumatology Meeting in San Diego
Drs. Clowse and Criscione-Schreiber review recent studies on the use of ustekinumab in the treatment of psoriatic arthritis and ankylosing spondylitis; they also discuss findings from the TICOPA Trial, which investigated a treat-to-target approach for psoriatic arthritis.
Drs. Clowse and Criscione-Schreiber explore the implications of data from recent lupus trials, including medication tapering, treatment adherence, investigational therapies, innovations in clinical trial design, and the reduction in efficacy of influenza vaccinations.